ProQR Therapeutics Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
ProQR Therapeutics N.V. - Ordinary Shares (PRQR)
Last proqr therapeutics n.v. - ordinary shares earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
proqr.com
Company Research
Source: Yahoo! Finance
Net loss: €2.69m (loss narrowed by 66% from 2Q 2023). €0.033 loss per share (improved from €0.099 loss in 2Q 2023). All figures shown in the chart above are for the trailing 12 month (TTM) period ProQR Therapeutics EPS Beats Expectations, Revenues Fall Short Revenue missed analyst estimates by 37%. Earnings per share (EPS) exceeded analyst estimates by 72%. Looking ahead, revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are up 12% from a week ago. Risk Analysis What about risks? Every company has them, and we've spotted 2 warning signs for ProQR Therapeutics (of which 1 is potentially serious!) you should know about. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com. This article by Simply Wall St is gene
Show less
Read more
Impact Snapshot
Event Time:
PRQR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRQR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRQR alerts
High impacting ProQR Therapeutics N.V. - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
PRQR
News
- ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare ConferenceGlobeNewswire
- ProQR Announces Second Quarter 2024 Operating and Financial ResultsGlobeNewswire
- ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.MarketBeat
PRQR
Earnings
- 8/8/24 - Beat
PRQR
Sec Filings
- 8/8/24 - Form 6-K
- PRQR's page on the SEC website